Representation and Medication Use in Juvenile Idiopathic Arthritis

Completed

• Conditions: Juvenile Idiopathic Arthritis

• Registration Number: NCT03892135
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

According to the International League of Associations for Rheumatology classification, Juvenile Idiopathic Arthritis (JIA) comprises a heterogeneous group of arthritis of unknown cause and with onset before 16 years of age, characterized by joint inflammation lasting for 6 or more weeks. Few studies exist regarding the care experience of children affected by this rheumatic condition. On the other hand, methotrexate and biologics constitute the primary treatment for children with JIA. As with adults undergoing the same treatment, adherence is critical. Difficulties for children to take the drugs have been reported. Notwithstanding, if adherence promotion in pediatric chronic conditions has been the subject of recommendations with regard to care management, the investigators lack information to understand the grounds for adherence specifically in JIA. In order to understand and decipher the parent-child adherence mechanisms and practices, the RUMAJI study will be conducted. Indeed, improving the relational approach between children and their caregivers as well as unrestricted drug adherence involves researching and understanding how appropriation of the disease and treatment could be achieved.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-04-01
• Primary Completion: 2017-10-01
• Study Completion: 2017-12-01
• Status Verified: 2019-03
• Study First Submitted: 2019-03-18
• Study First Submitted QC: 2019-03-25
• Study First Posted: 2019-03-27
• Last Update Submitted: 2019-04-25
• Last Update Posted: 2019-04-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Interview with parents	1 day	Interview with parents to learn about role of parents in the management of juvenile idiopathic arthritis in their children

Secondary Outcome Measures

Name	Time	Method
Interview with children	1 day	Interview with children to learn about role of children in the management of their juvenile idiopathic arthritis
Interview with physicians	1 day	Interview with physicians to learn about role of physicians in the management of juvenile idiopathic arthritis

Trial Locations

Locations (1)

Uhmontpellier; 🇫🇷 Montpellier, France